Global Human Factor VIII Concentrate Supply, Demand and Key Producers, 2023-2029
The global Human Factor VIII Concentrate market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Complementary therapy for prevention and treatment of hemophilia A acquired coagulation factor ? deficiency and von Willebrand's disease
This report studies the global Human Factor VIII Concentrate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Factor VIII Concentrate, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Factor VIII Concentrate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Factor VIII Concentrate total production and demand, 2018-2029, (K Units)
Global Human Factor VIII Concentrate total production value, 2018-2029, (USD Million)
Global Human Factor VIII Concentrate production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Factor VIII Concentrate consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Human Factor VIII Concentrate domestic production, consumption, key domestic manufacturers and share
Global Human Factor VIII Concentrate production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Human Factor VIII Concentrate production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Factor VIII Concentrate production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Human Factor VIII Concentrate market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novo Nordisk A/S, Shire (Baxter), Bayer, GC Pharma, Shanghai Raas Corp, Hualan Biological, Shandong Taibang Biological Products and Shanghai Xinxing Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Factor VIII Concentrate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Factor VIII Concentrate Market, By Region:
1. How big is the global Human Factor VIII Concentrate market?
2. What is the demand of the global Human Factor VIII Concentrate market?
3. What is the year over year growth of the global Human Factor VIII Concentrate market?
4. What is the production and production value of the global Human Factor VIII Concentrate market?
5. Who are the key producers in the global Human Factor VIII Concentrate market?
6. What are the growth factors driving the market demand?
Complementary therapy for prevention and treatment of hemophilia A acquired coagulation factor ? deficiency and von Willebrand's disease
This report studies the global Human Factor VIII Concentrate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Factor VIII Concentrate, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Factor VIII Concentrate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Factor VIII Concentrate total production and demand, 2018-2029, (K Units)
Global Human Factor VIII Concentrate total production value, 2018-2029, (USD Million)
Global Human Factor VIII Concentrate production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Factor VIII Concentrate consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Human Factor VIII Concentrate domestic production, consumption, key domestic manufacturers and share
Global Human Factor VIII Concentrate production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Human Factor VIII Concentrate production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Factor VIII Concentrate production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Human Factor VIII Concentrate market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novo Nordisk A/S, Shire (Baxter), Bayer, GC Pharma, Shanghai Raas Corp, Hualan Biological, Shandong Taibang Biological Products and Shanghai Xinxing Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Factor VIII Concentrate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Factor VIII Concentrate Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Blood Extraction
- Recombine
- Congenital Coagulation Factor VIII Deficiency
- Acquired Factor VIII Deficiency
- Von Willebrand's Disease
- Pfizer
- Novo Nordisk A/S
- Shire (Baxter)
- Bayer
- GC Pharma
- Shanghai Raas Corp
- Hualan Biological
- Shandong Taibang Biological Products
- Shanghai Xinxing Medicine
- SinoCell Tech
- CSL
- Grifols
- Biogen
- Octapharma
- NovoNordisk
1. How big is the global Human Factor VIII Concentrate market?
2. What is the demand of the global Human Factor VIII Concentrate market?
3. What is the year over year growth of the global Human Factor VIII Concentrate market?
4. What is the production and production value of the global Human Factor VIII Concentrate market?
5. Who are the key producers in the global Human Factor VIII Concentrate market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Human Factor VIII Concentrate Introduction
1.2 World Human Factor VIII Concentrate Supply & Forecast
1.2.1 World Human Factor VIII Concentrate Production Value (2018 & 2022 & 2029)
1.2.2 World Human Factor VIII Concentrate Production (2018-2029)
1.2.3 World Human Factor VIII Concentrate Pricing Trends (2018-2029)
1.3 World Human Factor VIII Concentrate Production by Region (Based on Production Site)
1.3.1 World Human Factor VIII Concentrate Production Value by Region (2018-2029)
1.3.2 World Human Factor VIII Concentrate Production by Region (2018-2029)
1.3.3 World Human Factor VIII Concentrate Average Price by Region (2018-2029)
1.3.4 North America Human Factor VIII Concentrate Production (2018-2029)
1.3.5 Europe Human Factor VIII Concentrate Production (2018-2029)
1.3.6 China Human Factor VIII Concentrate Production (2018-2029)
1.3.7 Japan Human Factor VIII Concentrate Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Factor VIII Concentrate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Factor VIII Concentrate Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Factor VIII Concentrate Demand (2018-2029)
2.2 World Human Factor VIII Concentrate Consumption by Region
2.2.1 World Human Factor VIII Concentrate Consumption by Region (2018-2023)
2.2.2 World Human Factor VIII Concentrate Consumption Forecast by Region (2024-2029)
2.3 United States Human Factor VIII Concentrate Consumption (2018-2029)
2.4 China Human Factor VIII Concentrate Consumption (2018-2029)
2.5 Europe Human Factor VIII Concentrate Consumption (2018-2029)
2.6 Japan Human Factor VIII Concentrate Consumption (2018-2029)
2.7 South Korea Human Factor VIII Concentrate Consumption (2018-2029)
2.8 ASEAN Human Factor VIII Concentrate Consumption (2018-2029)
2.9 India Human Factor VIII Concentrate Consumption (2018-2029)
3 WORLD HUMAN FACTOR VIII CONCENTRATE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Factor VIII Concentrate Production Value by Manufacturer (2018-2023)
3.2 World Human Factor VIII Concentrate Production by Manufacturer (2018-2023)
3.3 World Human Factor VIII Concentrate Average Price by Manufacturer (2018-2023)
3.4 Human Factor VIII Concentrate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Factor VIII Concentrate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Factor VIII Concentrate in 2022
3.5.3 Global Concentration Ratios (CR8) for Human Factor VIII Concentrate in 2022
3.6 Human Factor VIII Concentrate Market: Overall Company Footprint Analysis
3.6.1 Human Factor VIII Concentrate Market: Region Footprint
3.6.2 Human Factor VIII Concentrate Market: Company Product Type Footprint
3.6.3 Human Factor VIII Concentrate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Factor VIII Concentrate Production Value Comparison
4.1.1 United States VS China: Human Factor VIII Concentrate Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Human Factor VIII Concentrate Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Human Factor VIII Concentrate Production Comparison
4.2.1 United States VS China: Human Factor VIII Concentrate Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Factor VIII Concentrate Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Human Factor VIII Concentrate Consumption Comparison
4.3.1 United States VS China: Human Factor VIII Concentrate Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Human Factor VIII Concentrate Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Human Factor VIII Concentrate Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Human Factor VIII Concentrate Production Value (2018-2023)
4.4.3 United States Based Manufacturers Human Factor VIII Concentrate Production (2018-2023)
4.5 China Based Human Factor VIII Concentrate Manufacturers and Market Share
4.5.1 China Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Human Factor VIII Concentrate Production Value (2018-2023)
4.5.3 China Based Manufacturers Human Factor VIII Concentrate Production (2018-2023)
4.6 Rest of World Based Human Factor VIII Concentrate Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Human Factor VIII Concentrate Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Human Factor VIII Concentrate Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Factor VIII Concentrate Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Blood Extraction
5.2.2 Recombine
5.3 Market Segment by Type
5.3.1 World Human Factor VIII Concentrate Production by Type (2018-2029)
5.3.2 World Human Factor VIII Concentrate Production Value by Type (2018-2029)
5.3.3 World Human Factor VIII Concentrate Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Factor VIII Concentrate Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Congenital Coagulation Factor VIII Deficiency
6.2.2 Acquired Factor VIII Deficiency
6.2.3 Von Willebrand's Disease
6.3 Market Segment by Application
6.3.1 World Human Factor VIII Concentrate Production by Application (2018-2029)
6.3.2 World Human Factor VIII Concentrate Production Value by Application (2018-2029)
6.3.3 World Human Factor VIII Concentrate Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Human Factor VIII Concentrate Product and Services
7.1.4 Pfizer Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Novo Nordisk A/S
7.2.1 Novo Nordisk A/S Details
7.2.2 Novo Nordisk A/S Major Business
7.2.3 Novo Nordisk A/S Human Factor VIII Concentrate Product and Services
7.2.4 Novo Nordisk A/S Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Novo Nordisk A/S Recent Developments/Updates
7.2.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
7.3 Shire (Baxter)
7.3.1 Shire (Baxter) Details
7.3.2 Shire (Baxter) Major Business
7.3.3 Shire (Baxter) Human Factor VIII Concentrate Product and Services
7.3.4 Shire (Baxter) Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Shire (Baxter) Recent Developments/Updates
7.3.6 Shire (Baxter) Competitive Strengths & Weaknesses
7.4 Bayer
7.4.1 Bayer Details
7.4.2 Bayer Major Business
7.4.3 Bayer Human Factor VIII Concentrate Product and Services
7.4.4 Bayer Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Bayer Recent Developments/Updates
7.4.6 Bayer Competitive Strengths & Weaknesses
7.5 GC Pharma
7.5.1 GC Pharma Details
7.5.2 GC Pharma Major Business
7.5.3 GC Pharma Human Factor VIII Concentrate Product and Services
7.5.4 GC Pharma Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GC Pharma Recent Developments/Updates
7.5.6 GC Pharma Competitive Strengths & Weaknesses
7.6 Shanghai Raas Corp
7.6.1 Shanghai Raas Corp Details
7.6.2 Shanghai Raas Corp Major Business
7.6.3 Shanghai Raas Corp Human Factor VIII Concentrate Product and Services
7.6.4 Shanghai Raas Corp Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Shanghai Raas Corp Recent Developments/Updates
7.6.6 Shanghai Raas Corp Competitive Strengths & Weaknesses
7.7 Hualan Biological
7.7.1 Hualan Biological Details
7.7.2 Hualan Biological Major Business
7.7.3 Hualan Biological Human Factor VIII Concentrate Product and Services
7.7.4 Hualan Biological Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Hualan Biological Recent Developments/Updates
7.7.6 Hualan Biological Competitive Strengths & Weaknesses
7.8 Shandong Taibang Biological Products
7.8.1 Shandong Taibang Biological Products Details
7.8.2 Shandong Taibang Biological Products Major Business
7.8.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Product and Services
7.8.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Shandong Taibang Biological Products Recent Developments/Updates
7.8.6 Shandong Taibang Biological Products Competitive Strengths & Weaknesses
7.9 Shanghai Xinxing Medicine
7.9.1 Shanghai Xinxing Medicine Details
7.9.2 Shanghai Xinxing Medicine Major Business
7.9.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product and Services
7.9.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Shanghai Xinxing Medicine Recent Developments/Updates
7.9.6 Shanghai Xinxing Medicine Competitive Strengths & Weaknesses
7.10 SinoCell Tech
7.10.1 SinoCell Tech Details
7.10.2 SinoCell Tech Major Business
7.10.3 SinoCell Tech Human Factor VIII Concentrate Product and Services
7.10.4 SinoCell Tech Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 SinoCell Tech Recent Developments/Updates
7.10.6 SinoCell Tech Competitive Strengths & Weaknesses
7.11 CSL
7.11.1 CSL Details
7.11.2 CSL Major Business
7.11.3 CSL Human Factor VIII Concentrate Product and Services
7.11.4 CSL Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 CSL Recent Developments/Updates
7.11.6 CSL Competitive Strengths & Weaknesses
7.12 Grifols
7.12.1 Grifols Details
7.12.2 Grifols Major Business
7.12.3 Grifols Human Factor VIII Concentrate Product and Services
7.12.4 Grifols Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Grifols Recent Developments/Updates
7.12.6 Grifols Competitive Strengths & Weaknesses
7.13 Biogen
7.13.1 Biogen Details
7.13.2 Biogen Major Business
7.13.3 Biogen Human Factor VIII Concentrate Product and Services
7.13.4 Biogen Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Biogen Recent Developments/Updates
7.13.6 Biogen Competitive Strengths & Weaknesses
7.14 Octapharma
7.14.1 Octapharma Details
7.14.2 Octapharma Major Business
7.14.3 Octapharma Human Factor VIII Concentrate Product and Services
7.14.4 Octapharma Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Octapharma Recent Developments/Updates
7.14.6 Octapharma Competitive Strengths & Weaknesses
7.15 NovoNordisk
7.15.1 NovoNordisk Details
7.15.2 NovoNordisk Major Business
7.15.3 NovoNordisk Human Factor VIII Concentrate Product and Services
7.15.4 NovoNordisk Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 NovoNordisk Recent Developments/Updates
7.15.6 NovoNordisk Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Factor VIII Concentrate Industry Chain
8.2 Human Factor VIII Concentrate Upstream Analysis
8.2.1 Human Factor VIII Concentrate Core Raw Materials
8.2.2 Main Manufacturers of Human Factor VIII Concentrate Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Human Factor VIII Concentrate Production Mode
8.6 Human Factor VIII Concentrate Procurement Model
8.7 Human Factor VIII Concentrate Industry Sales Model and Sales Channels
8.7.1 Human Factor VIII Concentrate Sales Model
8.7.2 Human Factor VIII Concentrate Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Human Factor VIII Concentrate Introduction
1.2 World Human Factor VIII Concentrate Supply & Forecast
1.2.1 World Human Factor VIII Concentrate Production Value (2018 & 2022 & 2029)
1.2.2 World Human Factor VIII Concentrate Production (2018-2029)
1.2.3 World Human Factor VIII Concentrate Pricing Trends (2018-2029)
1.3 World Human Factor VIII Concentrate Production by Region (Based on Production Site)
1.3.1 World Human Factor VIII Concentrate Production Value by Region (2018-2029)
1.3.2 World Human Factor VIII Concentrate Production by Region (2018-2029)
1.3.3 World Human Factor VIII Concentrate Average Price by Region (2018-2029)
1.3.4 North America Human Factor VIII Concentrate Production (2018-2029)
1.3.5 Europe Human Factor VIII Concentrate Production (2018-2029)
1.3.6 China Human Factor VIII Concentrate Production (2018-2029)
1.3.7 Japan Human Factor VIII Concentrate Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Factor VIII Concentrate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Factor VIII Concentrate Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Factor VIII Concentrate Demand (2018-2029)
2.2 World Human Factor VIII Concentrate Consumption by Region
2.2.1 World Human Factor VIII Concentrate Consumption by Region (2018-2023)
2.2.2 World Human Factor VIII Concentrate Consumption Forecast by Region (2024-2029)
2.3 United States Human Factor VIII Concentrate Consumption (2018-2029)
2.4 China Human Factor VIII Concentrate Consumption (2018-2029)
2.5 Europe Human Factor VIII Concentrate Consumption (2018-2029)
2.6 Japan Human Factor VIII Concentrate Consumption (2018-2029)
2.7 South Korea Human Factor VIII Concentrate Consumption (2018-2029)
2.8 ASEAN Human Factor VIII Concentrate Consumption (2018-2029)
2.9 India Human Factor VIII Concentrate Consumption (2018-2029)
3 WORLD HUMAN FACTOR VIII CONCENTRATE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Factor VIII Concentrate Production Value by Manufacturer (2018-2023)
3.2 World Human Factor VIII Concentrate Production by Manufacturer (2018-2023)
3.3 World Human Factor VIII Concentrate Average Price by Manufacturer (2018-2023)
3.4 Human Factor VIII Concentrate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Factor VIII Concentrate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Factor VIII Concentrate in 2022
3.5.3 Global Concentration Ratios (CR8) for Human Factor VIII Concentrate in 2022
3.6 Human Factor VIII Concentrate Market: Overall Company Footprint Analysis
3.6.1 Human Factor VIII Concentrate Market: Region Footprint
3.6.2 Human Factor VIII Concentrate Market: Company Product Type Footprint
3.6.3 Human Factor VIII Concentrate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Factor VIII Concentrate Production Value Comparison
4.1.1 United States VS China: Human Factor VIII Concentrate Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Human Factor VIII Concentrate Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Human Factor VIII Concentrate Production Comparison
4.2.1 United States VS China: Human Factor VIII Concentrate Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Factor VIII Concentrate Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Human Factor VIII Concentrate Consumption Comparison
4.3.1 United States VS China: Human Factor VIII Concentrate Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Human Factor VIII Concentrate Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Human Factor VIII Concentrate Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Human Factor VIII Concentrate Production Value (2018-2023)
4.4.3 United States Based Manufacturers Human Factor VIII Concentrate Production (2018-2023)
4.5 China Based Human Factor VIII Concentrate Manufacturers and Market Share
4.5.1 China Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Human Factor VIII Concentrate Production Value (2018-2023)
4.5.3 China Based Manufacturers Human Factor VIII Concentrate Production (2018-2023)
4.6 Rest of World Based Human Factor VIII Concentrate Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Human Factor VIII Concentrate Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Human Factor VIII Concentrate Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Factor VIII Concentrate Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Blood Extraction
5.2.2 Recombine
5.3 Market Segment by Type
5.3.1 World Human Factor VIII Concentrate Production by Type (2018-2029)
5.3.2 World Human Factor VIII Concentrate Production Value by Type (2018-2029)
5.3.3 World Human Factor VIII Concentrate Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Factor VIII Concentrate Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Congenital Coagulation Factor VIII Deficiency
6.2.2 Acquired Factor VIII Deficiency
6.2.3 Von Willebrand's Disease
6.3 Market Segment by Application
6.3.1 World Human Factor VIII Concentrate Production by Application (2018-2029)
6.3.2 World Human Factor VIII Concentrate Production Value by Application (2018-2029)
6.3.3 World Human Factor VIII Concentrate Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Human Factor VIII Concentrate Product and Services
7.1.4 Pfizer Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Novo Nordisk A/S
7.2.1 Novo Nordisk A/S Details
7.2.2 Novo Nordisk A/S Major Business
7.2.3 Novo Nordisk A/S Human Factor VIII Concentrate Product and Services
7.2.4 Novo Nordisk A/S Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Novo Nordisk A/S Recent Developments/Updates
7.2.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
7.3 Shire (Baxter)
7.3.1 Shire (Baxter) Details
7.3.2 Shire (Baxter) Major Business
7.3.3 Shire (Baxter) Human Factor VIII Concentrate Product and Services
7.3.4 Shire (Baxter) Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Shire (Baxter) Recent Developments/Updates
7.3.6 Shire (Baxter) Competitive Strengths & Weaknesses
7.4 Bayer
7.4.1 Bayer Details
7.4.2 Bayer Major Business
7.4.3 Bayer Human Factor VIII Concentrate Product and Services
7.4.4 Bayer Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Bayer Recent Developments/Updates
7.4.6 Bayer Competitive Strengths & Weaknesses
7.5 GC Pharma
7.5.1 GC Pharma Details
7.5.2 GC Pharma Major Business
7.5.3 GC Pharma Human Factor VIII Concentrate Product and Services
7.5.4 GC Pharma Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GC Pharma Recent Developments/Updates
7.5.6 GC Pharma Competitive Strengths & Weaknesses
7.6 Shanghai Raas Corp
7.6.1 Shanghai Raas Corp Details
7.6.2 Shanghai Raas Corp Major Business
7.6.3 Shanghai Raas Corp Human Factor VIII Concentrate Product and Services
7.6.4 Shanghai Raas Corp Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Shanghai Raas Corp Recent Developments/Updates
7.6.6 Shanghai Raas Corp Competitive Strengths & Weaknesses
7.7 Hualan Biological
7.7.1 Hualan Biological Details
7.7.2 Hualan Biological Major Business
7.7.3 Hualan Biological Human Factor VIII Concentrate Product and Services
7.7.4 Hualan Biological Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Hualan Biological Recent Developments/Updates
7.7.6 Hualan Biological Competitive Strengths & Weaknesses
7.8 Shandong Taibang Biological Products
7.8.1 Shandong Taibang Biological Products Details
7.8.2 Shandong Taibang Biological Products Major Business
7.8.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Product and Services
7.8.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Shandong Taibang Biological Products Recent Developments/Updates
7.8.6 Shandong Taibang Biological Products Competitive Strengths & Weaknesses
7.9 Shanghai Xinxing Medicine
7.9.1 Shanghai Xinxing Medicine Details
7.9.2 Shanghai Xinxing Medicine Major Business
7.9.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product and Services
7.9.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Shanghai Xinxing Medicine Recent Developments/Updates
7.9.6 Shanghai Xinxing Medicine Competitive Strengths & Weaknesses
7.10 SinoCell Tech
7.10.1 SinoCell Tech Details
7.10.2 SinoCell Tech Major Business
7.10.3 SinoCell Tech Human Factor VIII Concentrate Product and Services
7.10.4 SinoCell Tech Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 SinoCell Tech Recent Developments/Updates
7.10.6 SinoCell Tech Competitive Strengths & Weaknesses
7.11 CSL
7.11.1 CSL Details
7.11.2 CSL Major Business
7.11.3 CSL Human Factor VIII Concentrate Product and Services
7.11.4 CSL Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 CSL Recent Developments/Updates
7.11.6 CSL Competitive Strengths & Weaknesses
7.12 Grifols
7.12.1 Grifols Details
7.12.2 Grifols Major Business
7.12.3 Grifols Human Factor VIII Concentrate Product and Services
7.12.4 Grifols Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Grifols Recent Developments/Updates
7.12.6 Grifols Competitive Strengths & Weaknesses
7.13 Biogen
7.13.1 Biogen Details
7.13.2 Biogen Major Business
7.13.3 Biogen Human Factor VIII Concentrate Product and Services
7.13.4 Biogen Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Biogen Recent Developments/Updates
7.13.6 Biogen Competitive Strengths & Weaknesses
7.14 Octapharma
7.14.1 Octapharma Details
7.14.2 Octapharma Major Business
7.14.3 Octapharma Human Factor VIII Concentrate Product and Services
7.14.4 Octapharma Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Octapharma Recent Developments/Updates
7.14.6 Octapharma Competitive Strengths & Weaknesses
7.15 NovoNordisk
7.15.1 NovoNordisk Details
7.15.2 NovoNordisk Major Business
7.15.3 NovoNordisk Human Factor VIII Concentrate Product and Services
7.15.4 NovoNordisk Human Factor VIII Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 NovoNordisk Recent Developments/Updates
7.15.6 NovoNordisk Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Factor VIII Concentrate Industry Chain
8.2 Human Factor VIII Concentrate Upstream Analysis
8.2.1 Human Factor VIII Concentrate Core Raw Materials
8.2.2 Main Manufacturers of Human Factor VIII Concentrate Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Human Factor VIII Concentrate Production Mode
8.6 Human Factor VIII Concentrate Procurement Model
8.7 Human Factor VIII Concentrate Industry Sales Model and Sales Channels
8.7.1 Human Factor VIII Concentrate Sales Model
8.7.2 Human Factor VIII Concentrate Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Human Factor VIII Concentrate Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Human Factor VIII Concentrate Production Value by Region (2018-2023) & (USD Million)
Table 3. World Human Factor VIII Concentrate Production Value by Region (2024-2029) & (USD Million)
Table 4. World Human Factor VIII Concentrate Production Value Market Share by Region (2018-2023)
Table 5. World Human Factor VIII Concentrate Production Value Market Share by Region (2024-2029)
Table 6. World Human Factor VIII Concentrate Production by Region (2018-2023) & (K Units)
Table 7. World Human Factor VIII Concentrate Production by Region (2024-2029) & (K Units)
Table 8. World Human Factor VIII Concentrate Production Market Share by Region (2018-2023)
Table 9. World Human Factor VIII Concentrate Production Market Share by Region (2024-2029)
Table 10. World Human Factor VIII Concentrate Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Human Factor VIII Concentrate Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Human Factor VIII Concentrate Major Market Trends
Table 13. World Human Factor VIII Concentrate Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Human Factor VIII Concentrate Consumption by Region (2018-2023) & (K Units)
Table 15. World Human Factor VIII Concentrate Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Human Factor VIII Concentrate Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Human Factor VIII Concentrate Producers in 2022
Table 18. World Human Factor VIII Concentrate Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Human Factor VIII Concentrate Producers in 2022
Table 20. World Human Factor VIII Concentrate Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Human Factor VIII Concentrate Company Evaluation Quadrant
Table 22. World Human Factor VIII Concentrate Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Human Factor VIII Concentrate Production Site of Key Manufacturer
Table 24. Human Factor VIII Concentrate Market: Company Product Type Footprint
Table 25. Human Factor VIII Concentrate Market: Company Product Application Footprint
Table 26. Human Factor VIII Concentrate Competitive Factors
Table 27. Human Factor VIII Concentrate New Entrant and Capacity Expansion Plans
Table 28. Human Factor VIII Concentrate Mergers & Acquisitions Activity
Table 29. United States VS China Human Factor VIII Concentrate Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Human Factor VIII Concentrate Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Human Factor VIII Concentrate Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Human Factor VIII Concentrate Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Human Factor VIII Concentrate Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Human Factor VIII Concentrate Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Human Factor VIII Concentrate Production Market Share (2018-2023)
Table 37. China Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Human Factor VIII Concentrate Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Human Factor VIII Concentrate Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Human Factor VIII Concentrate Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Human Factor VIII Concentrate Production Market Share (2018-2023)
Table 42. Rest of World Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Human Factor VIII Concentrate Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Human Factor VIII Concentrate Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Human Factor VIII Concentrate Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Human Factor VIII Concentrate Production Market Share (2018-2023)
Table 47. World Human Factor VIII Concentrate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Human Factor VIII Concentrate Production by Type (2018-2023) & (K Units)
Table 49. World Human Factor VIII Concentrate Production by Type (2024-2029) & (K Units)
Table 50. World Human Factor VIII Concentrate Production Value by Type (2018-2023) & (USD Million)
Table 51. World Human Factor VIII Concentrate Production Value by Type (2024-2029) & (USD Million)
Table 52. World Human Factor VIII Concentrate Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Human Factor VIII Concentrate Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Human Factor VIII Concentrate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Human Factor VIII Concentrate Production by Application (2018-2023) & (K Units)
Table 56. World Human Factor VIII Concentrate Production by Application (2024-2029) & (K Units)
Table 57. World Human Factor VIII Concentrate Production Value by Application (2018-2023) & (USD Million)
Table 58. World Human Factor VIII Concentrate Production Value by Application (2024-2029) & (USD Million)
Table 59. World Human Factor VIII Concentrate Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Human Factor VIII Concentrate Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Human Factor VIII Concentrate Product and Services
Table 64. Pfizer Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 68. Novo Nordisk A/S Major Business
Table 69. Novo Nordisk A/S Human Factor VIII Concentrate Product and Services
Table 70. Novo Nordisk A/S Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novo Nordisk A/S Recent Developments/Updates
Table 72. Novo Nordisk A/S Competitive Strengths & Weaknesses
Table 73. Shire (Baxter) Basic Information, Manufacturing Base and Competitors
Table 74. Shire (Baxter) Major Business
Table 75. Shire (Baxter) Human Factor VIII Concentrate Product and Services
Table 76. Shire (Baxter) Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shire (Baxter) Recent Developments/Updates
Table 78. Shire (Baxter) Competitive Strengths & Weaknesses
Table 79. Bayer Basic Information, Manufacturing Base and Competitors
Table 80. Bayer Major Business
Table 81. Bayer Human Factor VIII Concentrate Product and Services
Table 82. Bayer Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bayer Recent Developments/Updates
Table 84. Bayer Competitive Strengths & Weaknesses
Table 85. GC Pharma Basic Information, Manufacturing Base and Competitors
Table 86. GC Pharma Major Business
Table 87. GC Pharma Human Factor VIII Concentrate Product and Services
Table 88. GC Pharma Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GC Pharma Recent Developments/Updates
Table 90. GC Pharma Competitive Strengths & Weaknesses
Table 91. Shanghai Raas Corp Basic Information, Manufacturing Base and Competitors
Table 92. Shanghai Raas Corp Major Business
Table 93. Shanghai Raas Corp Human Factor VIII Concentrate Product and Services
Table 94. Shanghai Raas Corp Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Shanghai Raas Corp Recent Developments/Updates
Table 96. Shanghai Raas Corp Competitive Strengths & Weaknesses
Table 97. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 98. Hualan Biological Major Business
Table 99. Hualan Biological Human Factor VIII Concentrate Product and Services
Table 100. Hualan Biological Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Hualan Biological Recent Developments/Updates
Table 102. Hualan Biological Competitive Strengths & Weaknesses
Table 103. Shandong Taibang Biological Products Basic Information, Manufacturing Base and Competitors
Table 104. Shandong Taibang Biological Products Major Business
Table 105. Shandong Taibang Biological Products Human Factor VIII Concentrate Product and Services
Table 106. Shandong Taibang Biological Products Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Shandong Taibang Biological Products Recent Developments/Updates
Table 108. Shandong Taibang Biological Products Competitive Strengths & Weaknesses
Table 109. Shanghai Xinxing Medicine Basic Information, Manufacturing Base and Competitors
Table 110. Shanghai Xinxing Medicine Major Business
Table 111. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product and Services
Table 112. Shanghai Xinxing Medicine Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Shanghai Xinxing Medicine Recent Developments/Updates
Table 114. Shanghai Xinxing Medicine Competitive Strengths & Weaknesses
Table 115. SinoCell Tech Basic Information, Manufacturing Base and Competitors
Table 116. SinoCell Tech Major Business
Table 117. SinoCell Tech Human Factor VIII Concentrate Product and Services
Table 118. SinoCell Tech Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. SinoCell Tech Recent Developments/Updates
Table 120. SinoCell Tech Competitive Strengths & Weaknesses
Table 121. CSL Basic Information, Manufacturing Base and Competitors
Table 122. CSL Major Business
Table 123. CSL Human Factor VIII Concentrate Product and Services
Table 124. CSL Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. CSL Recent Developments/Updates
Table 126. CSL Competitive Strengths & Weaknesses
Table 127. Grifols Basic Information, Manufacturing Base and Competitors
Table 128. Grifols Major Business
Table 129. Grifols Human Factor VIII Concentrate Product and Services
Table 130. Grifols Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Grifols Recent Developments/Updates
Table 132. Grifols Competitive Strengths & Weaknesses
Table 133. Biogen Basic Information, Manufacturing Base and Competitors
Table 134. Biogen Major Business
Table 135. Biogen Human Factor VIII Concentrate Product and Services
Table 136. Biogen Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Biogen Recent Developments/Updates
Table 138. Biogen Competitive Strengths & Weaknesses
Table 139. Octapharma Basic Information, Manufacturing Base and Competitors
Table 140. Octapharma Major Business
Table 141. Octapharma Human Factor VIII Concentrate Product and Services
Table 142. Octapharma Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Octapharma Recent Developments/Updates
Table 144. NovoNordisk Basic Information, Manufacturing Base and Competitors
Table 145. NovoNordisk Major Business
Table 146. NovoNordisk Human Factor VIII Concentrate Product and Services
Table 147. NovoNordisk Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Human Factor VIII Concentrate Upstream (Raw Materials)
Table 149. Human Factor VIII Concentrate Typical Customers
Table 150. Human Factor VIII Concentrate Typical Distributors
Table 1. World Human Factor VIII Concentrate Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Human Factor VIII Concentrate Production Value by Region (2018-2023) & (USD Million)
Table 3. World Human Factor VIII Concentrate Production Value by Region (2024-2029) & (USD Million)
Table 4. World Human Factor VIII Concentrate Production Value Market Share by Region (2018-2023)
Table 5. World Human Factor VIII Concentrate Production Value Market Share by Region (2024-2029)
Table 6. World Human Factor VIII Concentrate Production by Region (2018-2023) & (K Units)
Table 7. World Human Factor VIII Concentrate Production by Region (2024-2029) & (K Units)
Table 8. World Human Factor VIII Concentrate Production Market Share by Region (2018-2023)
Table 9. World Human Factor VIII Concentrate Production Market Share by Region (2024-2029)
Table 10. World Human Factor VIII Concentrate Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Human Factor VIII Concentrate Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Human Factor VIII Concentrate Major Market Trends
Table 13. World Human Factor VIII Concentrate Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Human Factor VIII Concentrate Consumption by Region (2018-2023) & (K Units)
Table 15. World Human Factor VIII Concentrate Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Human Factor VIII Concentrate Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Human Factor VIII Concentrate Producers in 2022
Table 18. World Human Factor VIII Concentrate Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Human Factor VIII Concentrate Producers in 2022
Table 20. World Human Factor VIII Concentrate Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Human Factor VIII Concentrate Company Evaluation Quadrant
Table 22. World Human Factor VIII Concentrate Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Human Factor VIII Concentrate Production Site of Key Manufacturer
Table 24. Human Factor VIII Concentrate Market: Company Product Type Footprint
Table 25. Human Factor VIII Concentrate Market: Company Product Application Footprint
Table 26. Human Factor VIII Concentrate Competitive Factors
Table 27. Human Factor VIII Concentrate New Entrant and Capacity Expansion Plans
Table 28. Human Factor VIII Concentrate Mergers & Acquisitions Activity
Table 29. United States VS China Human Factor VIII Concentrate Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Human Factor VIII Concentrate Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Human Factor VIII Concentrate Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Human Factor VIII Concentrate Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Human Factor VIII Concentrate Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Human Factor VIII Concentrate Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Human Factor VIII Concentrate Production Market Share (2018-2023)
Table 37. China Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Human Factor VIII Concentrate Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Human Factor VIII Concentrate Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Human Factor VIII Concentrate Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Human Factor VIII Concentrate Production Market Share (2018-2023)
Table 42. Rest of World Based Human Factor VIII Concentrate Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Human Factor VIII Concentrate Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Human Factor VIII Concentrate Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Human Factor VIII Concentrate Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Human Factor VIII Concentrate Production Market Share (2018-2023)
Table 47. World Human Factor VIII Concentrate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Human Factor VIII Concentrate Production by Type (2018-2023) & (K Units)
Table 49. World Human Factor VIII Concentrate Production by Type (2024-2029) & (K Units)
Table 50. World Human Factor VIII Concentrate Production Value by Type (2018-2023) & (USD Million)
Table 51. World Human Factor VIII Concentrate Production Value by Type (2024-2029) & (USD Million)
Table 52. World Human Factor VIII Concentrate Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Human Factor VIII Concentrate Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Human Factor VIII Concentrate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Human Factor VIII Concentrate Production by Application (2018-2023) & (K Units)
Table 56. World Human Factor VIII Concentrate Production by Application (2024-2029) & (K Units)
Table 57. World Human Factor VIII Concentrate Production Value by Application (2018-2023) & (USD Million)
Table 58. World Human Factor VIII Concentrate Production Value by Application (2024-2029) & (USD Million)
Table 59. World Human Factor VIII Concentrate Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Human Factor VIII Concentrate Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Human Factor VIII Concentrate Product and Services
Table 64. Pfizer Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 68. Novo Nordisk A/S Major Business
Table 69. Novo Nordisk A/S Human Factor VIII Concentrate Product and Services
Table 70. Novo Nordisk A/S Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novo Nordisk A/S Recent Developments/Updates
Table 72. Novo Nordisk A/S Competitive Strengths & Weaknesses
Table 73. Shire (Baxter) Basic Information, Manufacturing Base and Competitors
Table 74. Shire (Baxter) Major Business
Table 75. Shire (Baxter) Human Factor VIII Concentrate Product and Services
Table 76. Shire (Baxter) Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shire (Baxter) Recent Developments/Updates
Table 78. Shire (Baxter) Competitive Strengths & Weaknesses
Table 79. Bayer Basic Information, Manufacturing Base and Competitors
Table 80. Bayer Major Business
Table 81. Bayer Human Factor VIII Concentrate Product and Services
Table 82. Bayer Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bayer Recent Developments/Updates
Table 84. Bayer Competitive Strengths & Weaknesses
Table 85. GC Pharma Basic Information, Manufacturing Base and Competitors
Table 86. GC Pharma Major Business
Table 87. GC Pharma Human Factor VIII Concentrate Product and Services
Table 88. GC Pharma Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GC Pharma Recent Developments/Updates
Table 90. GC Pharma Competitive Strengths & Weaknesses
Table 91. Shanghai Raas Corp Basic Information, Manufacturing Base and Competitors
Table 92. Shanghai Raas Corp Major Business
Table 93. Shanghai Raas Corp Human Factor VIII Concentrate Product and Services
Table 94. Shanghai Raas Corp Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Shanghai Raas Corp Recent Developments/Updates
Table 96. Shanghai Raas Corp Competitive Strengths & Weaknesses
Table 97. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 98. Hualan Biological Major Business
Table 99. Hualan Biological Human Factor VIII Concentrate Product and Services
Table 100. Hualan Biological Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Hualan Biological Recent Developments/Updates
Table 102. Hualan Biological Competitive Strengths & Weaknesses
Table 103. Shandong Taibang Biological Products Basic Information, Manufacturing Base and Competitors
Table 104. Shandong Taibang Biological Products Major Business
Table 105. Shandong Taibang Biological Products Human Factor VIII Concentrate Product and Services
Table 106. Shandong Taibang Biological Products Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Shandong Taibang Biological Products Recent Developments/Updates
Table 108. Shandong Taibang Biological Products Competitive Strengths & Weaknesses
Table 109. Shanghai Xinxing Medicine Basic Information, Manufacturing Base and Competitors
Table 110. Shanghai Xinxing Medicine Major Business
Table 111. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product and Services
Table 112. Shanghai Xinxing Medicine Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Shanghai Xinxing Medicine Recent Developments/Updates
Table 114. Shanghai Xinxing Medicine Competitive Strengths & Weaknesses
Table 115. SinoCell Tech Basic Information, Manufacturing Base and Competitors
Table 116. SinoCell Tech Major Business
Table 117. SinoCell Tech Human Factor VIII Concentrate Product and Services
Table 118. SinoCell Tech Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. SinoCell Tech Recent Developments/Updates
Table 120. SinoCell Tech Competitive Strengths & Weaknesses
Table 121. CSL Basic Information, Manufacturing Base and Competitors
Table 122. CSL Major Business
Table 123. CSL Human Factor VIII Concentrate Product and Services
Table 124. CSL Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. CSL Recent Developments/Updates
Table 126. CSL Competitive Strengths & Weaknesses
Table 127. Grifols Basic Information, Manufacturing Base and Competitors
Table 128. Grifols Major Business
Table 129. Grifols Human Factor VIII Concentrate Product and Services
Table 130. Grifols Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Grifols Recent Developments/Updates
Table 132. Grifols Competitive Strengths & Weaknesses
Table 133. Biogen Basic Information, Manufacturing Base and Competitors
Table 134. Biogen Major Business
Table 135. Biogen Human Factor VIII Concentrate Product and Services
Table 136. Biogen Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Biogen Recent Developments/Updates
Table 138. Biogen Competitive Strengths & Weaknesses
Table 139. Octapharma Basic Information, Manufacturing Base and Competitors
Table 140. Octapharma Major Business
Table 141. Octapharma Human Factor VIII Concentrate Product and Services
Table 142. Octapharma Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Octapharma Recent Developments/Updates
Table 144. NovoNordisk Basic Information, Manufacturing Base and Competitors
Table 145. NovoNordisk Major Business
Table 146. NovoNordisk Human Factor VIII Concentrate Product and Services
Table 147. NovoNordisk Human Factor VIII Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Human Factor VIII Concentrate Upstream (Raw Materials)
Table 149. Human Factor VIII Concentrate Typical Customers
Table 150. Human Factor VIII Concentrate Typical Distributors
LIST OF FIGURES
Figure 1. Human Factor VIII Concentrate Picture
Figure 2. World Human Factor VIII Concentrate Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Factor VIII Concentrate Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Human Factor VIII Concentrate Production (2018-2029) & (K Units)
Figure 5. World Human Factor VIII Concentrate Average Price (2018-2029) & (US$/Unit)
Figure 6. World Human Factor VIII Concentrate Production Value Market Share by Region (2018-2029)
Figure 7. World Human Factor VIII Concentrate Production Market Share by Region (2018-2029)
Figure 8. North America Human Factor VIII Concentrate Production (2018-2029) & (K Units)
Figure 9. Europe Human Factor VIII Concentrate Production (2018-2029) & (K Units)
Figure 10. China Human Factor VIII Concentrate Production (2018-2029) & (K Units)
Figure 11. Japan Human Factor VIII Concentrate Production (2018-2029) & (K Units)
Figure 12. Human Factor VIII Concentrate Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 15. World Human Factor VIII Concentrate Consumption Market Share by Region (2018-2029)
Figure 16. United States Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 17. China Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 18. Europe Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 19. Japan Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 20. South Korea Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 22. India Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Human Factor VIII Concentrate by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Factor VIII Concentrate Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Factor VIII Concentrate Markets in 2022
Figure 26. United States VS China: Human Factor VIII Concentrate Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Human Factor VIII Concentrate Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Factor VIII Concentrate Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Human Factor VIII Concentrate Production Market Share 2022
Figure 30. China Based Manufacturers Human Factor VIII Concentrate Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Human Factor VIII Concentrate Production Market Share 2022
Figure 32. World Human Factor VIII Concentrate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Human Factor VIII Concentrate Production Value Market Share by Type in 2022
Figure 34. Blood Extraction
Figure 35. Recombine
Figure 36. World Human Factor VIII Concentrate Production Market Share by Type (2018-2029)
Figure 37. World Human Factor VIII Concentrate Production Value Market Share by Type (2018-2029)
Figure 38. World Human Factor VIII Concentrate Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Human Factor VIII Concentrate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Human Factor VIII Concentrate Production Value Market Share by Application in 2022
Figure 41. Congenital Coagulation Factor VIII Deficiency
Figure 42. Acquired Factor VIII Deficiency
Figure 43. Von Willebrand's Disease
Figure 44. World Human Factor VIII Concentrate Production Market Share by Application (2018-2029)
Figure 45. World Human Factor VIII Concentrate Production Value Market Share by Application (2018-2029)
Figure 46. World Human Factor VIII Concentrate Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Human Factor VIII Concentrate Industry Chain
Figure 48. Human Factor VIII Concentrate Procurement Model
Figure 49. Human Factor VIII Concentrate Sales Model
Figure 50. Human Factor VIII Concentrate Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Human Factor VIII Concentrate Picture
Figure 2. World Human Factor VIII Concentrate Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Factor VIII Concentrate Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Human Factor VIII Concentrate Production (2018-2029) & (K Units)
Figure 5. World Human Factor VIII Concentrate Average Price (2018-2029) & (US$/Unit)
Figure 6. World Human Factor VIII Concentrate Production Value Market Share by Region (2018-2029)
Figure 7. World Human Factor VIII Concentrate Production Market Share by Region (2018-2029)
Figure 8. North America Human Factor VIII Concentrate Production (2018-2029) & (K Units)
Figure 9. Europe Human Factor VIII Concentrate Production (2018-2029) & (K Units)
Figure 10. China Human Factor VIII Concentrate Production (2018-2029) & (K Units)
Figure 11. Japan Human Factor VIII Concentrate Production (2018-2029) & (K Units)
Figure 12. Human Factor VIII Concentrate Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 15. World Human Factor VIII Concentrate Consumption Market Share by Region (2018-2029)
Figure 16. United States Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 17. China Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 18. Europe Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 19. Japan Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 20. South Korea Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 22. India Human Factor VIII Concentrate Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Human Factor VIII Concentrate by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Factor VIII Concentrate Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Factor VIII Concentrate Markets in 2022
Figure 26. United States VS China: Human Factor VIII Concentrate Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Human Factor VIII Concentrate Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Factor VIII Concentrate Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Human Factor VIII Concentrate Production Market Share 2022
Figure 30. China Based Manufacturers Human Factor VIII Concentrate Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Human Factor VIII Concentrate Production Market Share 2022
Figure 32. World Human Factor VIII Concentrate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Human Factor VIII Concentrate Production Value Market Share by Type in 2022
Figure 34. Blood Extraction
Figure 35. Recombine
Figure 36. World Human Factor VIII Concentrate Production Market Share by Type (2018-2029)
Figure 37. World Human Factor VIII Concentrate Production Value Market Share by Type (2018-2029)
Figure 38. World Human Factor VIII Concentrate Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Human Factor VIII Concentrate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Human Factor VIII Concentrate Production Value Market Share by Application in 2022
Figure 41. Congenital Coagulation Factor VIII Deficiency
Figure 42. Acquired Factor VIII Deficiency
Figure 43. Von Willebrand's Disease
Figure 44. World Human Factor VIII Concentrate Production Market Share by Application (2018-2029)
Figure 45. World Human Factor VIII Concentrate Production Value Market Share by Application (2018-2029)
Figure 46. World Human Factor VIII Concentrate Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Human Factor VIII Concentrate Industry Chain
Figure 48. Human Factor VIII Concentrate Procurement Model
Figure 49. Human Factor VIII Concentrate Sales Model
Figure 50. Human Factor VIII Concentrate Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
